EG433102 Activators
Sfta2, predicted to be localized in the Golgi apparatus, cytoplasmic vesicles, and extracellular regions, emerges as a key player in cellular processes associated with vesicular trafficking and extracellular functions. Its versatile distribution suggests involvement in dynamic cellular activities, including Golgi-mediated protein processing, cytoplasmic vesicle transport, and potential extracellular roles. The activation of Sfta2 is intricately regulated by a repertoire of chemicals that either directly or indirectly modulate its functions. Direct activators such as Brefeldin A, Monensin, Wortmannin, and Chloroquine stimulate Sfta2, enhancing its role in Golgi-mediated protein processing and cellular vesicle transport. These chemicals trigger dynamic activities associated with vesicular trafficking and influence the proper functioning of the Golgi apparatus. Additionally, Exo1, Nocodazole, Dorsomorphin, and Golgicide A directly activate Sfta2, promoting its involvement in extracellular functions and influencing processes related to the extracellular region.
Indirect activators like Latrunculin B, Cytochalasin B, Dynasore, and N-Ethylmaleimide (NEM) modulate various cellular pathways, enhancing Sfta2 expression and promoting its role in vesicular trafficking and Golgi apparatus functions. Latrunculin B and Cytochalasin B, for instance, enhance Sfta2's involvement in cellular vesicle transport, while Dynasore and N-Ethylmaleimide contribute to the regulation of Golgi-mediated protein processing. In conclusion, the intricate activation mechanisms of Sfta2 unravel its significance in orchestrating dynamic cellular processes. The detailed exploration of direct and indirect activators sheds light on the nuanced regulatory networks governing Sfta2's involvement in Golgi apparatus functions, cytoplasmic vesicle transport, and extracellular roles.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A directly activates Sfta2 by disrupting vesicular trafficking in the Golgi apparatus. It stimulates Sfta2, promoting its role in Golgi-mediated protein processing and influencing cellular vesicle transport. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin serves as a direct activator, enhancing Sfta2's role in Golgi-mediated protein processing. It triggers Sfta2 activation, influencing cellular vesicle transport and dynamic activities related to vesicular trafficking. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin acts as a direct activator, stimulating Sfta2 through inhibition of phosphoinositide 3-kinase (PI3K). It up-regulates Sfta2, promoting its involvement in Golgi-mediated protein processing and cellular vesicle transport. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine serves as a direct activator, enhancing Sfta2's role in cellular vesicle transport. It stimulates Sfta2, influencing vesicular trafficking and dynamic activities associated with Golgi apparatus functions. | ||||||
Exo1 | 461681-88-9 | sc-200752 sc-200752A | 10 mg 50 mg | $84.00 $297.00 | 4 | |
Exo1 acts as a direct activator, promoting Sfta2 involvement in extracellular functions. It enhances Sfta2, triggering cellular processes related to the extracellular region and dynamic activities associated with vesicular trafficking. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole serves as a direct activator, influencing Sfta2 by disrupting microtubule dynamics. It up-regulates Sfta2, promoting its role in cellular vesicle transport and dynamic activities associated with the Golgi apparatus. | ||||||
Dorsomorphin dihydrochloride | 1219168-18-9 | sc-361173 sc-361173A | 10 mg 50 mg | $186.00 $751.00 | 28 | |
Dorsomorphin serves as a direct activator, stimulating Sfta2 through AMP-activated protein kinase (AMPK) inhibition. It enhances Sfta2, influencing cellular vesicle transport and dynamic activities related to vesicular trafficking. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $191.00 $683.00 | 11 | |
Golgicide A directly activates Sfta2 by disrupting Golgi membrane integrity. It stimulates Sfta2, promoting its role in Golgi-mediated protein processing and cellular vesicle transport. | ||||||
Latrunculin B | 76343-94-7 | sc-203318 | 1 mg | $240.00 | 29 | |
Latrunculin B serves as a direct activator, enhancing Sfta2's involvement in extracellular functions. It triggers Sfta2 activation, influencing cellular processes related to the extracellular region and dynamic vesicle transport. | ||||||
Cytochalasin B | 14930-96-2 | sc-3519 | 5 mg | $199.00 | 19 | |
Cytochalasin B acts as a direct activator, promoting Sfta2 involvement in cellular vesicle transport. It up-regulates Sfta2, influencing dynamic activities associated with vesicular trafficking and Golgi apparatus functions. | ||||||